Vitamin B1 Thiamine — Beriberi and Wernicke

Thiamine (vitamin B1) deficiency is a preventable nutritional disorder resulting from insufficient intake or absorption of this water-soluble B vitamin, which serves as an essential cofactor for carbohydrate metabolism and myelin synthesis. The condition manifests across a spectrum ranging from subclinical deficiency to two major clinical syndromes: beriberi (peripheral neuropathy and/or cardiac dysfunction) and Wernicke encephalopathy (acute encephalopathy with ophthalmoplegia, ataxia, and confusion). Although most common in resource-limited settings with polished rice consumption and in wealthy nations among patients with severe alcohol use disorder, thiamine deficiency remains clinically significant because Wernicke encephalopathy is a medical emergency with high mortality if untreated and can rapidly progress to irreversible Korsakoff syndrome. The prevalence of Wernicke encephalopathy is estimated at 1-3% in autopsy series in developed countries, yet it is frequently underdiagnosed clinically, making recognition essential for Step 2 CK examination success.

Thiamine is converted to its active form, thiamine pyrophosphate (TPP), by thiamine pyrophosphokinase. TPP functions as an essential cofactor for three major enzyme complexes: (1) pyruvate dehydrogenase complex—converts pyruvate to acetyl-CoA in the tricarboxylic acid cycle; (2) α-ketoglutarate dehydrogenase—catalyzes oxidative decarboxylation in the citric acid cycle; and (3) transketolase—catalyzes nonoxidative pentose phosphate pathway reactions necessary for NADPH production and ribose synthesis. Tissues with the highest metabolic demands—particularly the central and peripheral nervous systems, myocardium, and skeletal muscles—are most vulnerable to thiamine deficiency because they depend critically on efficient oxidative glucose metabolism. Deficiency results in impaired ATP production, reduced NADPH availability for biosynthetic reactions and antioxidant defense (glutathione reduction), and accumulation of lactate and pyruvate with consequent metabolic acidosis.

The mamillary bodies, dorsomedial thalamus, periaqueductal gray matter, and brainstem nuclei are selectively vulnerable to thiamine deficiency due to their high metabolic rates and reliance on oxidative carbohydrate metabolism. Impaired transketolase activity in these regions leads to energy failure, accumulation of toxic metabolites (including lactate), increased oxidative stress from reduced NADPH-dependent antioxidant systems, and impaired myelin synthesis. This results in neuronal degeneration, astrocytic gliosis, and microhemorrhages, particularly in the mammillary bodies and medial thalamic nuclei. The acute presentation of Wernicke encephalopathy reflects this acute energy depletion. Progression to Korsakoff syndrome involves further thalamic and anterior temporal lobe damage with irreversible neuronal loss, particularly affecting dopaminergic and cholinergic systems, resulting in permanent anterograde and retrograde amnesia even after thiamine repletion.

In the peripheral nervous system, thiamine deficiency impairs transketolase-dependent pentose phosphate pathway metabolism in myelin-synthesizing Schwann cells and neuronal cell bodies, reducing NADPH availability for myelin lipid synthesis and membrane maintenance. This leads to segmental demyelination and axonal degeneration affecting both large myelinated fibers (causing sensory ataxia) and autonomic fibers. The wet beriberi presentation reflects additional cardiac involvement with energy depletion in myocardial cells, leading to dilated cardiomyopathy and high-output cardiac failure.

Myocardial thiamine deficiency impairs ATP synthesis and oxidative metabolism, causing cardiomyocyte dysfunction, reduced cardiac contractility, and heart failure. The heart compensates with hyperactivity and increased cardiac output (high-output state), leading to tachycardia, elevated cardiac output, widened pulse pressure, and eventually dilated cardiomyopathy. Pulmonary and systemic edema result from the combination of reduced myocardial contractility and compensatory peripheral vasodilation.

The most prevalent cause globally is insufficient dietary thiamine consumption, particularly in populations dependent on white (polished) rice as a staple carbohydrate source. The milling process removes the thiamine-rich bran and germ layers. This remains endemic in parts of Southeast Asia, India, and other regions where modern food processing has been adopted without thiamine fortification. Populations with severe poverty, famine conditions, or dependence on single refined carbohydrate sources face highest risk.

In the United States and other developed countries, chronic alcohol use disorder is responsible for the vast majority of thiamine deficiency cases. Multiple mechanisms contribute: (1) poor nutritional intake with calories derived from ethanol lacking micronutrients; (2) impaired thiamine absorption in the proximal small intestine due to alcohol-induced mucosal damage and reduced active transport; (3) impaired hepatic storage of thiamine; (4) accelerated degradation of TPP and urinary losses of thiamine metabolites; and (5) ethanol-induced pancreatic insufficiency reducing nutrient absorption. The risk increases substantially with >10 years of heavy alcohol consumption, though Wernicke encephalopathy can develop acutely in binge drinkers or even after moderate intake in severely malnourished individuals.

Persistent vomiting from any cause (including hyperemesis gravidarum, bulimia nervosa, or gastrointestinal obstruction) prevents oral thiamine intake. Additionally, acute refeeding—whether parenteral or enteral—without thiamine supplementation precipitates Wernicke encephalopathy in malnourished patients by several mechanisms: (1) carbohydrate metabolism increases thiamine demand acutely; (2) glucose infusions in deficient patients create a "pulling" effect on thiamine stores; and (3) this has become increasingly recognized in modern intensive care units during nutritional support of severely malnourished patients.

Thiamine is water-soluble and not protein-bound, making it readily dialyzable. Chronic hemodialysis patients lose thiamine across the dialysis membrane, particularly with high-flux membranes and extended dialysis sessions. This is compounded by uremia-associated anorexia and dietary restrictions limiting thiamine intake.

Conditions impairing thiamine absorption include celiac disease, Crohn's disease, tropical sprue, short bowel syndrome, post-bariatric surgery (particularly jejunoileal bypass), and primary biliary cholangitis. Additionally, loop diuretics and thiazide diuretics increase urinary thiamine losses.

Thyrotoxicosis, prolonged fever, intense exercise, and hyperthermia increase carbohydrate oxidation and thiamine demand, potentially unmasking subclinical deficiency.

Isoniazid and ethionamide directly antagonize thiamine metabolism and can precipitate deficiency even with adequate intake.

Wernicke encephalopathy classically presents as an acute triad of ophthalmoplegia, ataxia, and confusion (though all three are present in only 10-20% of cases, necessitating clinical suspicion for partial presentations). Ophthalmoplegia manifests as horizontal nystagmus (most common finding, present in ~90%), weakness of the sixth cranial nerve causing impaired lateral rectus function and gaze palsy (especially impaired convergence and lateral gaze), and vertical nystagmus or skew deviation. The nystagmus is often elicited by the Doll's head maneuver (oculocephalic reflex) or caloric testing showing intact brainstem-vestibular connections despite voluntary gaze impairment. Ataxia reflects cerebellar and proprioceptive dysfunction, presenting as truncal instability, broad-based gait disturbance (often more prominent than limb ataxia), and positive Romberg sign. Confusion ranges from subtle personality changes, disorientation, and apathy to profound delirium, reduced consciousness, and coma. Additional features include hypothermia, hypotension, and autonomic instability. The acute presentation occurs over hours to days and represents a medical emergency with mortality approaching 5-15% if untreated, rising to 35% if Korsakoff syndrome develops.

Wet beriberi presents acutely or subacutely with symptoms of high-output cardiac failure: dyspnea on exertion progressing to orthopnea and paroxysmal nocturnal dyspnea, lower extremity edema, fatigue, and chest discomfort. Patients may report sudden-onset palpitations or dyspnea precipitated by physical exertion in previously relatively asymptomatic individuals. The combination of high cardiac output (from compensatory tachycardia and peripheral vasodilation) with reduced myocardial contractility creates a unique hemodynamic state: warm extremities and bounding pulses (unlike cardiogenic shock) coexist with pulmonary edema and elevated jugular venous pressure.

Dry beriberi presents insidiously with distal symmetric peripheral neuropathy affecting lower extremities more than upper extremities. Symptoms include paresthesias (burning, tingling sensations), distal weakness (foot drop, difficulty climbing stairs), and gait disturbance. Progression is typically subacute to chronic (weeks to months) with functional decline. Pain is variable and may be severe (painful dysesthesias) or minimal.

Infantile beriberi: Occurs in exclusively breastfed infants (2 weeks to 2 months of age) whose mothers have thiamine deficiency, presenting with acute heart failure, seizures, and death if untreated; characterized by absent cry ("silent" presentation) and severe cardiomegaly.

Subacute combined degeneration-like syndrome: Some patients present with posterior column signs (sensory ataxia, loss of vibration and proprioception) mimicking vitamin B12 deficiency.

Gayet-Wernicke syndrome: Wernicke encephalopathy occurring in the setting of malignancy, particularly lymphoma and gastrointestinal cancers.

Diagnosis of Wernicke encephalopathy is fundamentally clinical and should be made on clinical grounds alone without waiting for diagnostic confirmation, as early treatment (within 24 hours of symptom onset) substantially reduces mortality and prevents progression to Korsakoff syndrome. Classic teaching emphasizes the clinical triad (ophthalmoplegia, ataxia, confusion), but diagnosis should be suspected with any two of the following: (1) dietary deficiency or risk factors for thiamine deficiency; (2) ophthalmoplegia or nystagmus; (3) cerebellar dysfunction (ataxia); (4) altered mental status; (5) hypotension or hypothermia. The Caine criteria (requiring 2 of 4 findings from dietary deficiency, ophthalmoplegia, cerebellar signs, or confused mental status) enhance diagnostic sensitivity and are widely used. Importantly, patients may not display the "classic triad"—many present with isolated ophthalmoplegia or nystagmus with subtle confusion, making recognition challenging.

Thiamine (vitamin B1) serum level: Normal serum thiamine level is 70-180 nmol/L (reference ranges vary by laboratory). Levels <40 nmol/L indicate deficiency, though levels in the low-normal range (40-70 nmol/L) may still represent functional deficiency. However, serum thiamine is not sensitive or specific and correlates poorly with tissue stores. False-negative serum thiamine levels can occur during Wernicke encephalopathy, particularly in acute presentations.

Thiamine pyrophosphate (TPP) level and transketolase activity: Erythrocyte transketolase activity and TPP levels are more specific measures of thiamine deficiency. Erythrocyte transketolase activity coefficient (ratio of TPP-stimulated to baseline transketolase activity) >1.25 indicates deficiency. An erythrocyte transketolase activity coefficient >1.5 is highly specific for thiamine deficiency. However, these tests are not widely available, require special handling, and results take time—limiting their clinical utility in acute presentations.

Other laboratory findings:

MRI brain (most sensitive imaging modality):

CT brain: Generally less sensitive than MRI but may show mammillary body atrophy or enhance with gadolinium; primarily used to exclude other acute diagnoses (hemorrhage, trauma, mass)

The Caine criteria for Wernicke encephalopathy (widely used in clinical research and practice):